Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BoNTA Dose-Ranging for Crow's Feet in Chinese Patients
NCT05324839Phase 1Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in periorbital wrinkles (4 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Change in Wrinkle Severity Rating Scale at 1 year. Started Feb 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
periorbital wrinkles
Beyond the preview
Go deeper on NCT05324839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05324839.